SCHEMBL3092337

SCHEMBL3092337

CCc1ccc(Cc2[c]oc3ccccc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.38
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 1/20 0.35
RECQL P46063 1/20 0.35
MAOB P27338 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
KIF11 P52732 1/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33
PTPN1 P18031 1/20 0.32
ACHE P22303 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2A6 P11509 1/20 0.32
GRM2 Q14416 1/20 0.32
CTSV O60911 1/20 0.31
CTSL P07711 1/20 0.31
SLC5A1 P13866 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3074399 0.87 NPC1 (0.35) ALDH1A1MAOBNPC1RAB9AMAPT
SCHEMBL2197293 0.86 CALM1 (0.41) MEN1KMT2AMAPTPTPN1
SCHEMBL3097229 0.83 VKORC1 (0.48) KDM4EALDH1A1MEN1KMT2ARAB9A
SCHEMBL3091034 0.83 TNKS (0.38) TP53ALDH1A1NPC1RAB9AKIF11
SCHEMBL3084454 0.83 MAOB (0.50) MAOBMEN1KMT2ANPC1RAB9A
SCHEMBL3538088 0.82 ALDH1A1 (0.33) TP53KDM4EALDH1A1MEN1KMT2A
SCHEMBL7969760 0.71 FAAH (0.39) MAPTPTPN1CTSVCTSL
SCHEMBL10514896 0.71 L3MBTL1 (0.33) KDM4EALDH1A1MAOBKMT2AMAPT
SCHEMBL28961655 0.71 ALDH1A1 (0.31) KDM4EALDH1A1MAPT
SCHEMBL443850 0.70 KDM4E (0.38) KDM4EALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8207134-B2 Fused ring spiroketal derivative and use thereof as anti-diabetic drug CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2012-06-26 US disclosed
US-20100234609-A1 FUSED RING SPIROKETAL DERIVATIVE AND USE THEREOF AS ANTI-DIABETIC DRUG CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2010-09-16 US disclosed
EP-2048152-A1 FUSED RING SPIROKETAL DERIVATIVE AND USE THEREOF AS DRUG FOR TREATING DIABETES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234609-A1 FUSED RING SPIROKETAL DERIVATIVE AND USE THEREOF AS ANTI-DIABETIC DRUG REN, WNK1, GCKR TP53 4276/4885KDM4E 2711/4885ALDH1A1 1026/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.